Purple Sweet Potato

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: immunity inflammation heart

Research Overview

Recent research on purple sweet potato (Ipomoea batatas L.) has focused most heavily on characterizing its bioactive constituents—especially polysaccharides and anthocyanins—and testing their biological activities in cell, fermentation, and animal models. Multiple studies isolate and structurally define distinct polysaccharide fractions (e.g., neutral glucans and alkali-soluble polysaccharides) using chromatographic purification and spectroscopic methods (HPLC/GC-MS/NMR), revealing heterogeneous monosaccharide compositions and linkage patterns. In parallel, metabolomics work (LC-MS/MS) has mapped thousands of secondary metabolites across sweet potato flesh colors, highlighting flavonoids/phenolic acids and anthocyanin-like compounds associated with purple pigmentation (e.g., peonidin/delphinidin-related profiles). A smaller but notable area examines food-system behavior (e.g., protein–anthocyanin binding) and environmental/food-safety aspects, including uptake and interaction of heavy metals (U, Cd) in purple sweet potato grown in contaminated conditions.

The strongest evidence from these studies supports that purple sweet potato–derived polysaccharides and anthocyanins can modulate inflammatory and oxidative-related endpoints in preclinical systems. Polysaccharide fractions repeatedly reduce pro-inflammatory mediators in LPS-stimulated macrophages (e.g., decreased NO and cytokines such as IL-6, IL-1β, TNF-α, with increased IL-10) and show in vivo anti-inflammatory effects in LPS-challenged mice; separate work reports inhibition of proliferation and apoptosis induction in a colon cancer cell line (HT-29). Anthocyanin preparations and monomers demonstrate antioxidant capacity in vitro, can inhibit glycation processes in model systems (including methylglyoxal trapping), and show microbiome-relevant effects in anaerobic fermentation (increased Bifidobacterium/Lactobacillus and higher SCFAs, with partial conversion to phenolic acids). Emerging animal evidence also suggests specific purple sweet potato components may ameliorate colonic inflammation (DSS colitis model) and that a newly described polysaccharide fraction may have preventive effects in a NAFLD model, though details and replication breadth are limited within the studies reviewed here.

Key gaps include translation to humans and standardization across studies. Many findings rely on in vitro assays or single animal models using chemically induced inflammation/metabolic disease, with limited information on bioavailability, dose–response relationships, active metabolite identification, and comparability across cultivars and extraction methods. More research is needed to connect structural features of specific polysaccharide/anthocyanin fractions to mechanism (e.g., receptor targets, signaling pathways, microbiome-mediated metabolites), to evaluate how food processing and protein-binding alter anthocyanin stability and bioactivity, and to conduct well-controlled human studies assessing clinically relevant endpoints (inflammation, metabolic liver outcomes, gut function). Additionally, the evidence on uranium/cadmium accumulation highlights a need for broader agronomic and food-safety investigations (soil conditions, cultivar differences, mitigation strategies) to ensure health claims are considered alongside contaminant risk.

1. What conditions has Purple Sweet Potato been studied for?

  • Cancer (in vitro): A purified purple sweet potato polysaccharide (PSP) was tested against HT-29 colon cancer cells for anti-proliferative/apoptosis effects.

  • Inflammation / immune signaling: Multiple purple sweet potato polysaccharides (e.g., PSPP-1; alkali-soluble polysaccharide ASPP) and anthocyanin preparations (free vs protein-bound) were studied in LPS-stimulated RAW264.7 macrophages; ASPP was also studied in LPS-treated mice.

  • Gut microbiome modulation (prebiotic-like effects): Purple sweet potato anthocyanins (PSPAs) were studied in an in vitro anaerobic fermentation model of human intestinal microbiota, including effects on bacterial populations and short-chain fatty acids (SCFAs).

  • Glycation-related processes (in vitro): Anthocyanins from purple sweet potato were evaluated in BSA-fructose and BSA-methylglyoxal (MGO) anti-glycation models (compared with other purple vegetables).

  • Ulcerative colitis / colonic inflammation (animal model): Pelargonidin-3-galactoside derived from purple sweet potato was studied in DSS-induced colitis in mice (abstract truncated but clearly indicates this model).

  • Fatty liver / hepatic lipid accumulation / obesity-related outcomes: A purple sweet potato anthocyanin fraction (AF) was studied in high-fat diet (HFD)-fed mice and in HepG2 hepatocytes, focusing on AMPK signaling and hepatic triglycerides.

  • Diabetes / hyperglycemia (animal model): Free anthocyanins and protein-bound anthocyanin compounds (FAC-PSP and p-BAC-PSP) were studied in HFD/streptozotocin-induced diabetic mice, including glucose tolerance and liver markers.

  • Hyperuricemia and kidney inflammation (animal model): Highly acylated anthocyanins from purple sweet potato (HAA-PSP) were studied in hyperuricemic mice treated with allopurinol (abstract truncated but indicates this context).

  • Cardiovascular/platelet function (phytochemicals): Sweet potato phenolics were investigated for potential anti-platelet aggregation activity (purple cultivar relevance implied, but abstract is truncated).

  • Food safety / heavy metal uptake (agronomic-toxicology): Purple sweet potato was studied for uranium (U) and cadmium (Cd) absorption/accumulation in a pot experiment, including effects on mineral nutrition and metabolomics.

  • Processing/stability research: Studies examined extraction parameters and stability/antioxidant activity of anthocyanins during processing (not a clinical condition, but relevant to real-world exposure).

2. Does it work in treating those conditions? Summarize the evidence.

  • Inflammation: Evidence is supportive in preclinical models.

    • ASPP polysaccharide: In LPS-stimulated RAW264.7 cells, ASPP reduced NO, IL-6, IL-1β, and TNF-α and increased IL-10; in LPS-treated mice, ASPP reduced IL-6, IL-1β, and TNF-α.

    • Anthocyanin preparations (p-BAC-PSP and FAC-PSP): In LPS-stimulated RAW264.7 cells, both showed anti-inflammatory effects; p-BAC-PSP reduced iNOS and TNF-α expression, suppressed NO/TNF-α release, reduced ROS via HO-1/Nrf2, and inhibited JNK/AP-1 signaling. The study reported no significant difference in anti-inflammatory effect between protein-bound and free anthocyanin forms.

    • PSPP-1 glucan: Reported as anti-inflammatory in LPS-induced RAW264.7 cells (mechanistic details truncated in the study).

  • Hepatic lipid accumulation / obesity-related outcomes: Evidence is supportive in mice and cell models.

    • Anthocyanin fraction (AF): In HFD-fed mice (4 weeks), AF (200 mg/kg/day) reduced weight gain, reduced hepatic triglyceride accumulation, and improved serum lipid parameters. In liver and HepG2 cells, AF increased AMPK and ACC phosphorylation and downregulated SREBP-1 and lipogenesis genes (ACC, FAS). Compound C (AMPK inhibitor) attenuated these effects in HepG2 cells, supporting an AMPK-mediated mechanism.

  • Diabetes/hyperglycemia: Evidence is supportive in an animal model, but not yet clinical.

    • FAC-PSP and p-BAC-PSP in diabetic mice: Both improved glucose tolerance and lipid metabolism and reduced oxidative stress and liver damage; mechanistically, both induced hepatic AMPK expression and improved proteins involved in glucose handling (e.g., GLUT2, glucokinase, insulin receptor α; abstract truncated but direction is clear).

  • Ulcerative colitis: Evidence exists in a mouse DSS model for a specific anthocyanin (pelargonidin-3-galactoside), but the study is truncated, so effect size and endpoints cannot be summarized reliably.

  • Anti-glycation: Purple sweet potato anthocyanins inhibited non-enzymatic glycation in BSA-fructose and BSA-MGO models and could trap MGO, but purple cabbage anthocyanins performed best in that comparison. This supports biochemical potential, not clinical efficacy.

  • Cancer (colon cancer cells): A purified polysaccharide (PSP) inhibited proliferation of HT-29 cells by inducing apoptosis (in vitro). This is early-stage evidence and does not establish effectiveness in humans.

  • Gut microbiome: In vitro fermentation with PSPAs increased Bifidobacterium and Lactobacillus/Enterococcus spp., decreased Bacteroides-Prevotella and Clostridium histolyticum, and increased total SCFAs (P < 0.05). This suggests prebiotic-like activity, but it is not a human clinical trial.

  • NAFLD prevention (polysaccharide PSPP-A): The study states PSPP-A had “certain preventive effects on NAFLD,” but key details (model, endpoints, magnitude) are truncated; therefore, the strength of evidence cannot be fully assessed from the provided text.

  • Hyperuricemia/kidney inflammation with allopurinol: Highly acylated anthocyanins (HAA-PSP) were studied in hyperuricemic mice receiving allopurinol, but the study is truncated, so conclusions cannot be confidently summarized.

Overall: The studies provide mostly in vitro and animal evidence. They support biological plausibility for anti-inflammatory, metabolic (AMPK-related), antioxidant, and microbiome-modulating effects, but do not establish clinical treatment efficacy in humans.

3. What health benefits does it have?

  • Anti-inflammatory effects (preclinical): Polysaccharides (e.g., ASPP) reduced pro-inflammatory mediators (NO, IL-6, IL-1β, TNF-α) and increased IL-10 in cell models; ASPP also reduced inflammatory cytokines in LPS-treated mice.

  • Antioxidant/oxidative stress modulation: Peonidin-based anthocyanins showed radical scavenging activity (e.g., DPPH and superoxide anion scavenging) in vitro. In macrophages, p-BAC-PSP reduced ROS via HO-1/Nrf2 signaling.

  • Metabolic benefits (preclinical): Anthocyanin fraction reduced hepatic triglyceride accumulation and improved serum lipids in HFD-fed mice, linked to AMPK activation and downregulation of SREBP-1-driven lipogenesis.

  • Glycemic support (preclinical): FAC-PSP and p-BAC-PSP improved glucose tolerance and markers of liver health/oxidative stress in diabetic mice, with mechanistic signals involving AMPK and glucose metabolism proteins (GLUT2, glucokinase, insulin receptor α).

  • Gut microbiome/SCFA production (in vitro): PSP anthocyanins increased beneficial taxa (Bifidobacterium; Lactobacillus/Enterococcus spp.) and increased total SCFAs; anthocyanins were partially fragmented to phenolic acids during fermentation, which may contribute to microbiome effects.

  • Anti-glycation potential (in vitro): Anthocyanins inhibited non-enzymatic glycosylation in BSA-fructose and BSA-MGO models and trapped MGO, suggesting potential relevance to glycation-associated chronic disease processes (not yet clinical).

  • Potential anti-tumor activity (in vitro): A 470 kDa neutral polysaccharide (PSP) induced apoptosis and inhibited proliferation in HT-29 colon cancer cells.

  • Rich phytochemical profile: Metabolomics across sweet potato flesh colors identified large numbers of secondary metabolites and highlighted differences in flavonoids/phenolic acids; delphinidin-like and paeoniflorin-like compounds were suggested contributors to purple coloration.

4. Does it have any downsides or side effects?

  • Heavy metal accumulation risk (context-dependent): In a pot experiment, purple sweet potato root tubers accumulated uranium (reported range 1.68–5.16 mg/kg; abstract truncated) and cadmium was also studied. This suggests a potential food safety downside if grown in contaminated soils (not an inherent “side effect,” but a real exposure risk).

  • Human side effects not established in these studies: The studies reviewed here largely involve in vitro and animal studies and do not report adverse event rates in humans. Therefore, tolerability and side-effect profiles for purple sweet potato extracts (polysaccharides/anthocyanins) remain uncertain from this evidence set.

  • General limitation relevant to “downsides”: Many studies use purified fractions (e.g., anthocyanin fraction at 200 mg/kg/day in mice; isolated polysaccharides with defined structures). These doses/forms may not reflect typical dietary intake, and safety at supplemental doses in humans cannot be inferred from the studies alone.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

No pharmacogenomic findings are described in the studies reviewed here.

  • No genotype-stratified results: None of the studies report outcomes by human genetic variants (e.g., AMPK pathway polymorphisms, inflammatory cytokine gene variants, urate transporter variants) or evaluate gene–supplement interactions.

  • Mechanistic pathways noted but not linked to genetics: Several mechanisms are highlighted (e.g., AMPK/ACC/SREBP-1 in lipid metabolism; HO-1/Nrf2 and JNK/AP-1 in inflammation/oxidative stress), which are biologically relevant to genetic variability, but the studies do not test whether specific variants modify response.

References

  1. Structural characterization and induction of tumor cell apoptosis of polysaccharide from purple sweet potato (Ipomoea batatas (L.) Lam).
    Meng Meng, Ying Sun, Yanlong Qi, Jin Xu, Jingge Sun, Yuhe Bai, Lirong Han, Ran Han, Lihua Hou, Huiqing Sun (2023) - International journal of biological macromolecules
  2. Absorption and interaction mechanisms of uranium & cadmium in purple sweet potato(Ipomoea batatas L.).
    Jin-Long Lai, Deng Zhang-Xuan, J I Xiao-Hui, Luo Xue-Gang (2020) - Journal of hazardous materials
  3. Purple Sweet Potato Polysaccharide Exerting an Anti-inflammatory Effect via a TLR-Mediated Pathway by Regulating Polarization and Inhibiting the Inflammasome Activation.
    Dongxue Song, Junbo Niu, Ziyi Zhang, Zhiwei Sun, Di Wang, Jun Li, Bo Yang, Na Ling, Chenfeng Ji (2024) - Journal of agricultural and food chemistry
  4. Accumulation patterns of flavonoids and phenolic acids in different colored sweet potato flesh revealed based on untargeted metabolomics.
    Xiaolin Wan, Jiaqi Wu, Xiuzhi Wang, Lingjun Cui, Qiang Xiao (2024) - Food chemistry: X
  5. Structural characterization and anti-inflammatory activity of alkali-soluble polysaccharides from purple sweet potato.
    Hong Chen, Jian Sun, Jun Liu, Yarun Gou, Xin Zhang, Xiaonan Wu, Rui Sun, Sixue Tang, Juan Kan, Chunlu Qian, Nianfeng Zhang, Changhai Jin (2019) - International journal of biological macromolecules
  6. The Modulatory Effect of Anthocyanins from Purple Sweet Potato on Human Intestinal Microbiota in Vitro.
    Xin Zhang, Yang Yang, Zufang Wu, Peifang Weng (2016) - Journal of agricultural and food chemistry
  7. Anti-glycation and anti-inflammatory activities of anthocyanins from purple vegetables.
    Qingchao Gao, Rong Ma, Lu Shi, Shulin Wang, Ying Liang, Zhiyong Zhang (2023) - Food & function
  8. Anthocyanin Extracted from Purple Sweet Potato Alleviates Dextran Sulfate Sodium-Induced Colitis in Mice by Suppressing Pyroptosis and Altering Intestinal Flora Structure.
    Jing Chen, Fei Jiang, Nana Xu, Guokai Dong, Jiebang Jiang, Meng Wang, Cong Li, Rongpeng Li (2024) - Journal of medicinal food
  9. Antioxidant and prebiotic activity of five peonidin-based anthocyanins extracted from purple sweet potato (Ipomoea batatas (L.) Lam.).
    Hanju Sun, Pingping Zhang, Yongsheng Zhu, Qiuyan Lou, Shudong He (2018) - Scientific reports
  10. Extraction, purification, structural characterization, and hepatoprotective effect of the polysaccharide from purple sweet potato.
    Chenjing Li, Yihua Feng, Jingyao Li, Rui Lian, Liehao Qin, Chunling Wang (2023) - Journal of the science of food and agriculture
  11. The anti-inflammatory potential of protein-bound anthocyanin compounds from purple sweet potato in LPS-induced RAW264.7 macrophages.
    Tian Jiang, Jian Zhou, Wei Liu, Wen Tao, Jingren He, Weiping Jin, Heng Guo, Ning Yang, Yubao Li (2020) - Food research international (Ottawa, Ont.)
  12. Purple sweet potato anthocyanins attenuate hepatic lipid accumulation through activating adenosine monophosphate-activated protein kinase in human HepG2 cells and obese mice.
    Yong Pil Hwang, Jae Ho Choi, Eun Hee Han, Hyung Gyun Kim, Ji-Hyang Wee, Kyung Ok Jung, Kyung Hee Jung, Kwang-Il Kwon, Tae Cheon Jeong, Young Chul Chung, Hye Gwang Jeong (2011) - Nutrition research (New York, N.Y.)
  13. Highly Acylated Anthocyanins from Purple Sweet Potato ( Ipomoea batatas L.) Alleviate Hyperuricemia and Kidney Inflammation in Hyperuricemic Mice: Possible Attenuation Effects on Allopurinol.
    Zi-Cheng Zhang, Qing Zhou, Yang Yang, Yu Wang, Jiu-Liang Zhang (2019) - Journal of agricultural and food chemistry
  14. Protein-Bound Anthocyanin Compounds of Purple Sweet Potato Ameliorate Hyperglycemia by Regulating Hepatic Glucose Metabolism in High-Fat Diet/Streptozotocin-Induced Diabetic Mice.
    Tian Jiang, Xiaoyan Shuai, Jia Li, Ning Yang, Li Deng, Shuyi Li, Yi He, Heng Guo, Yubao Li, Jingren He (2020) - Journal of agricultural and food chemistry
  15. Phenolic profile, cheminformatics, and antiplatelet aggregation activity of orange and purple sweet potato (Ipomoea batatas L.) storage roots.
    Lyanne Rodriguez, Óscar Adrian Muñoz-Bernal, Eduardo Fuentes, Emilio Alvarez-Parrilla, Iván Palomo, Abraham Wall-Medrano (2024) - Food chemistry
  16. Stability and Quality of Anthocyanin in Purple Sweet Potato Extracts.
    Chin-Chia Chen, Chi Lin, Min-Hung Chen, Po-Yuan Chiang (2019) - Foods (Basel, Switzerland)
  17. Purple Sweet Potato Powder Containing Anthocyanin Mitigates High-Fat-Diet-Induced Dry Eye Disease.
    Ming-Cheng Chiang, Ying-Chung Liu, Bo-Yi Chen, Dai-Lin Wu, Chia-Lian Wu, Chun-Wen Cheng, Wen-Lung Chang, Huei-Jane Lee (2023) - International journal of molecular sciences
  18. Effect of purple sweet potato-derived anthocyanins on heat stress response in Wenchang chickens and preliminary mechanism study.
    Xin Fang, Keyi Nong, Xinyun Qin, Zhineng Liu, Feng Gao, Yuanli Jing, Haokai Fan, Zihan Wang, Xuemei Wang, Haiwen Zhang (2023) - Poultry science
  19. Effects and mechanism of natural phenolic acids/fatty acids on copigmentation of purple sweet potato anthocyanins.
    Xiaorui Lv, Jianlou Mu, Wenxiu Wang, Yaqiong Liu, Xiaomin Lu, Jianfeng Sun, Jie Wang, Qianyun Ma (2022) - Current research in food science


Related

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!